Previous Article | Next Article 
Infection and Immunity, June 2007, p. 2689-2698, Vol. 75, No. 6
0019-9567/07/$08.00+0 doi:10.1128/IAI.01875-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Murine Aerosol Challenge Model of Anthrax
Crystal L. Loving,1
Mary Kennett,2
Gloria M. Lee,1
Vanessa K. Grippe,1 and
Tod J. Merkel1*
Laboratory of Respiratory and Special Pathogens, Center for Biologics Evaluation and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, Maryland 20892,1
Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, State College, Pennysylvania2
Received 28 November 2006/
Returned for modification 14 February 2007/
Accepted 28 February 2007
The availability of relevant and useful animal models is critical for progress in the development of effective vaccines and therapeutics. The infection of rabbits and non-human primates with fully virulent Bacillus anthracis spores provides two excellent models of anthrax disease. However, the high cost of procuring and housing these animals and the specialized facilities required to deliver fully virulent spores limit their practical use in early stages of product development. Conversely, the small size and low cost associated with using mice makes this animal model more practical for conducting experiments in which large numbers of animals are required. In addition, the availability of knockout strains and well-characterized immunological reagents makes it possible to perform studies in mice that cannot be performed easily in other species. Although we, along with others, have used the mouse aerosol challenge model to examine the outcome of B. anthracis infection, a detailed characterization of the disease is lacking. The current study utilizes a murine aerosol challenge model to investigate disease progression, innate cytokine responses, and histological changes during the course of anthrax after challenge with aerosolized spores. Our results show that anthrax disease progression in a complement-deficient mouse after challenge with aerosolized Sterne spores is similar to that described for other species, including rabbits and non-human primates, challenged with fully virulent B. anthracis. Thus, the murine aerosol challenge model is both useful and relevant and provides a means to further investigate the host response and mechanisms of B. anthracis pathogenesis.
* Corresponding author. Mailing address: Laboratory of Respiratory and Special Pathogens, DBPAP/CBER/FDA, Building 29, Room 418, 29 Lincoln Drive, Bethesda, MD 20892. Phone: (301) 496-5564. Fax: (301) 402-2776. E-mail:
merkel{at}cber.fda.gov
Published ahead of print on 12 March 2007.
Editor: V. J. DiRita
Infection and Immunity, June 2007, p. 2689-2698, Vol. 75, No. 6
0019-9567/07/$08.00+0 doi:10.1128/IAI.01875-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Loving, C. L., Osorio, M., Kim, Y.-G., Nunez, G., Hughes, M. A., Merkel, T. J.
(2009). Nod1/Nod2-Mediated Recognition Plays a Critical Role in Induction of Adaptive Immunity to Anthrax after Aerosol Exposure. Infect. Immun.
77: 4529-4537
[Abstract]
[Full Text]
-
Cote, C. K., Bozue, J., Twenhafel, N., Welkos, S. L.
(2009). Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model. J Med Microbiol
58: 816-825
[Abstract]
[Full Text]
-
Osorio, M., Wu, Y., Singh, S., Merkel, T. J., Bhattacharyya, S., Blake, M. S., Kopecko, D. J.
(2009). Anthrax Protective Antigen Delivered by Salmonella enterica Serovar Typhi Ty21a Protects Mice from a Lethal Anthrax Spore Challenge. Infect. Immun.
77: 1475-1482
[Abstract]
[Full Text]
-
Loving, C. L., Khurana, T., Osorio, M., Lee, G. M., Kelly, V. K., Stibitz, S., Merkel, T. J.
(2009). Role of Anthrax Toxins in Dissemination, Disease Progression, and Induction of Protective Adaptive Immunity in the Mouse Aerosol Challenge Model. Infect. Immun.
77: 255-265
[Abstract]
[Full Text]
-
Chand, H. S., Drysdale, M., Lovchik, J., Koehler, T. M., Lipscomb, M. F., Lyons, C. R.
(2009). Discriminating Virulence Mechanisms among Bacillus anthracis Strains by Using a Murine Subcutaneous Infection Model. Infect. Immun.
77: 429-435
[Abstract]
[Full Text]
-
Lisanby, M. W., Swiecki, M. K., Dizon, B. L. P., Pflughoeft, K. J., Koehler, T. M., Kearney, J. F.
(2008). Cathelicidin Administration Protects Mice from Bacillus anthracis Spore Challenge. J. Immunol.
181: 4989-5000
[Abstract]
[Full Text]
-
Heine, H. S., Bassett, J., Miller, L., Bassett, A., Ivins, B. E., Lehoux, D., Arhin, F. F., Parr, T. R. Jr., Moeck, G.
(2008). Efficacy of Oritavancin in a Murine Model of Bacillus anthracis Spore Inhalation Anthrax. Antimicrob. Agents Chemother.
52: 3350-3357
[Abstract]
[Full Text]
-
Russell, B. H., Liu, Q., Jenkins, S. A., Tuvim, M. J., Dickey, B. F., Xu, Y.
(2008). In Vivo Demonstration and Quantification of Intracellular Bacillus anthracis in Lung Epithelial Cells. Infect. Immun.
76: 3975-3983
[Abstract]
[Full Text]
-
Warfel, J. M., D'Agnillo, F.
(2008). Anthrax Lethal Toxin Enhances TNF-Induced Endothelial VCAM-1 Expression via an IFN Regulatory Factor-1-Dependent Mechanism. J. Immunol.
180: 7516-7524
[Abstract]
[Full Text]
-
Harvill, E. T., Osorio, M., Loving, C. L., Lee, G. M., Kelly, V. K., Merkel, T. J.
(2008). Anamnestic Protective Immunity to Bacillus anthracis Is Antibody Mediated but Independent of Complement and Fc Receptors. Infect. Immun.
76: 2177-2182
[Abstract]
[Full Text]
-
Sanz, P., Teel, L. D., Alem, F., Carvalho, H. M., Darnell, S. C., O'Brien, A. D.
(2008). Detection of Bacillus anthracis Spore Germination In Vivo by Bioluminescence Imaging. Infect. Immun.
76: 1036-1047
[Abstract]
[Full Text]